Biogen may have found its CEO in Mathai Mammen – former head of research and development in pharmaceuticals at Johnson & Johnson – following the pending departure of current company head Michel Vounatsos.
https://www.pharmalive.com/wp-content/uploads/2022/03/Appeals-Court-Upholds-Decision-for-Mylan-Generic-of-Biogen-MS-Drug-BioSpace-3-17-22.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-10-10 11:26:242022-10-10 11:26:24Biogen looks at former J&J exec as potential CEO candidate
